Spunbound Nonwovens Market Outlook, Opportunity Analysis, and forecast 2023

Spunbound nonwovens market is projected to reach $17,651.9 million by 2023,The market growth is mainly driven by the rising demand for these fabrics for the manufacturing of hygiene and personal care products, such as diapers, wipes, sanitary napkins, underpads, and personal wipes.

Spunbound nonwoven is a fabric made by bonding staple fibers and long fibers together. In the spunbound manufacturing process, fibers are spun and dispersed into a web using deflectors, which form a continuous fabric known as spunbound nonwoven.

To Browse Full Report Visit Here: https://www.psmarketresearch.com/market-analysis/spunbound-nonwovens-market

In terms of value, polypropylene has been contributing the largest share to the spunbound nonwovens market, owing to its relatively low cost and high strength as compared to other material types. Some of the major products manufactured using polypropylene are baby, female, and adult hygiene diapers; drapes; bags; surgical disposables; and wipes. Medical is expected to be the fastest-growing application area in the spunbound nonwovens market in the coming years. The growing penetration of healthcare services and rising healthcare expenditure are boosting the demand for these fabrics in the medical industry.

Globally, APAC has been leading the spunbound nonwovens market in terms of value and is estimated to hold more than 40.0% share in the market in 2017. China, India, and Japan are among the world’s most populated countries and generate high demand for the fabric for the manufacturing of personal hygiene products. Also, rapid industrialization in these countries is expected to boost the consumption of the fabric in automotive, building and construction, and packaging industries. Besides, growing population and expanding industrial base are expected to contribute to the growth of the market in APAC.

Additionally, countries such as Japan, Germany, and Italy are witnessing rapid growth in their geriatric population, which is likely to boost the demand for adult incontinence products. Due to the aforementioned factors, the global spunbound nonwovens market is expected to witness considerable growth during the forecast period.

Request For Sample Pages: https://www.psmarketresearch.com/market-analysis/spunbound-nonwovens-market/report-sample

Countries like China, India, Nigeria, Indonesia, Poland, and Malaysia have witnessed rapid economic transformation in the past few decades. Majority of these nations have a high population growth rate along with improved standard of living. These factors make these developing countries suitable markets for personal care and hygiene, and medical products. Besides, these countries have fast-growing construction and automotive industries, which are major end users of spunbound nonwovens. Hence, developing countries with a high economic growth rate are expected to contribute to the spunbound nonwovens market growth.

Some of the major players operating in the global spunbound nonwovens market are PEGAS NONWOVENS SA, Mitsui Chemicals Inc., Kimberly-Clark Corporation, Berry Global Inc., Toray Industries Inc., Schouw & Co., Johns Manville Corporation, Asahi Kasei Corporation, Radici Partecipazioni SpA, and DowDuPont Inc.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:

P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

Air Quality Monitoring Market Scenario, Leading Players, Segments Analysis and Growth Drivers to 2022

The air quality monitoring market size is set to reach $6.0 billion by 2022, growing at a CAGR of 8.8% between 2016-2022. The AQM market is primarily driven by increasing level of air pollution across the globe, increasing awareness regarding environmental and healthcare implications of air pollution and favorable government regulations for AQM.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/air-quality-monitoring-devices-market/report-sample

In terms of product type, the AQM market has been segmented into indoor air quality monitor and outdoor air quality monitor. The indoor monitor accounted for the major share in the global market in 2015, whereas the outdoor monitor market is expected to witness the highest growth during 2016 – 2022.

In terms of pollutant type, the AQM market has been segmented into chemical pollutant, biological pollutant and physical pollutant. The chemical pollutant segment accounted for the major share in the global market in 2015, and it is also expected to witness the highest growth during 2016 – 2022.

In terms of sampling method, the AQM market has been segmented into continuous AQM, manual AQM, passive AQM, intermittent AQM. The continuous sampling method of AQM accounted for the major share in the global market in 2015, and it is also expected to witness the highest growth during 2016 – 2022.

Explore Report at: https://www.psmarketresearch.com/market-analysis/air-quality-monitoring-devices-market

In terms of end-user, the AQM market has been segmented into government agencies & academic institutes, commercial & residential users, petrochemical industry, power generation plants, pharmaceutical industry and others. The government agencies & academic institutes segment accounted for the major share in the global market in 2015, and commercial & residential users is expected to witness the highest growth during 2016 – 2022.

Some of the major players operating in the AQM market include Thermo Fisher Scientific Inc., Merck KGaA, Teledyne Technologies Incorporated, HORIBA, Ltd., Emerson Electric Co., General Electric Company, TSI Incorporated, 3M Company, and Siemens AG.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
P&S Market Research

347, 5th Ave. #1402

New York City, NY - 10016

Toll-free: +1-888-778-7886 (USA/Canada)

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Dental Adhesives and Sealants Market Growth And Demand Forecast To 2023

The global dental adhesives and sealants market is a vital market owing to the increase in the need of proper oral treatment. Dental adhesives are used to ensure that denture is at its place during daily activity. They are applied in diverse formulations such as powders, liquids, wafers, creams and pads. Similarly, dental sealants are barriers that help in preventing cavities. Plastic resins are primarily used to make this material and is usually applied on the chewing surface of the back of a tooth as they are most susceptible to oral decay.

Access Full Report : https://www.psmarketresearch.com/market-analysis/dental-adhesives-and-sealants-market

The global dental adhesives and sealants market is expected to showcase a significant growth of during the forecast period (2017-2023). This market growth can be attributed to the increase in improper food habits in the younger generation and the rising aging population in countries like Japan and China. Additionally, the rising population and the increasing concern of the people regarding oral care is further expected to drive the dental adhesives and sealants market during the forecast period.

The market for dental adhesives and sealants on the basis of their form is segmented as water based, solvent based, radiation cured and others. The radiation cured form of dental adhesives and sealants dominates the dental adhesives and sealants market owing to its high dentin bond strength. Additionally, the market on the basis of dental application is segmented as denture bonding agents, pit & fissure sealants, restorative adhesives, orthodontic bonding agents, luting cements, tray adhesives and dental surgical tissue bonding.

The key trend observed in the study includes factors such as the improper food habits and the increasing awareness related to proper oral hygiene. Oral diseases are a major health concern owing to their higher prevalence and their effects on the individual’s quality of life. According to the World Health Organisation “Promotion of oral health is a cost-effective strategy to reduce the burden of oral disease and maintain oral health and quality of life.” Periodontal disease, dental caries, malocclusion and oral cancer are among the most prevalent dental diseases affecting people worldwide. 

Request For Sample Pages: https://www.psmarketresearch.com/market-analysis/dental-adhesives-and-sealants-market/report-sample

The key driver observed in the study includes the increasing number of the patient pool for dental care. Accessing dentistry for both primary and secondary care can help identify the type of dental disease. Primary care like oral maxillofacial surgery whereas secondary care such as orthodontic problems can increase the demand for dental diagnosis, in turn, driving the growth of the dental adhesives and sealants market.

The global dental adhesives and sealants market has a lot of potential scope in it. The major players in the dental adhesives and sealants market are adopting significant competitive strategies such as mergers, acquisitions and joint ventures to hold a competitive stance in the global dental adhesives and sealants market.

Contact:

347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

North America to Contribute over 42% to the Global Active Implantable Medical Devices Market By 2025

The global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of neurological disorders. Development of subcutaneous implantable cardioverter defibrillators along with the increasing demand from developing nations is expected to create ample growth opportunities in the global active implantable medical devices market.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/active-implantable-medical-devices-market/report-sample

As per the findings of research, implantable cardioverter defibrillators held the largest share in the global active implantable medical devices market in 2016, primarily due to the development of technologically advanced devices and increasing prevalence of cardiovascular diseases. The neurostimulators market is expected to witness the highest growth during the forecast period. This growth of neurostimulators is attributed to the increasing incidence of neurological disorders and increasing demand from emerging economies. Among different type of implantable cardioverter defibrillators, transevenous implantable cardioverter defibrillators held larger share in the global active implantable medical devices market in 2016, and it is also expected to witness higher growth during the forecast period. Increasing research and development activities and rising compliance for technological innovations and data driven customizations are driving the growth of the global transvenous implantable cardioverter market.

Explore Report at: https://www.psmarketresearch.com/market-analysis/active-implantable-medical-devices-market

Key companies in the active implantable medical devices market are acquiring other companies to strengthen their position in the global market. In January 2017, Abbott completed the acquisition of St. Jude Medical, Inc., including its atrial fibrillation, structural heart and heart failure business as well as neuromodulation business. Similarly, in January 2015, Medtronic plc completed the acquisition of Covidien plc. Under the terms of the acquisition agreement, Medtronic, Inc. and Covidien plc are now combined under Medtronic plc. The acquisition strengthened position of the company in the global market with a large number of product offerings.

Some of the other key players in the market include Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd., Sonova Holding AG, and MED-EL.

Ulcerative Colitis Therapeutics - Pipeline Analysis, Clinical Trials and Results, 2017

The ulcerative colitis pipeline analysis report covers approximately 89 drug candidates in different stages of development.

Ulcerative colitis is a chronic inflammatory disease, which basically affect colonic mucosa. The main identified symptoms of the disease are bloody diarrhea, abdominal cramps and fatigue. Some of the other symptoms include, fever, vomiting, anorexia, abdominal distension and bloating. The treatment approaches to this disease mostly include the use of small molecules and monoclonal antibodies, which are being developed to target and reduce the inflammatory mediators.

Browse Detailed Report Description at: https://www.psmarketresearch.com/market-analysis/ulcerative-colitis-pipeline-analysis

The research found that different companies are engaged in the collaboration for ulcerative colitis. In June, 2015 Lycera Corp. and Celgene Corporation collaborated for the development of Lycera Corp. drug candidate for the treatment of ulcerative colitis. Celgene obtained the exclusive right to acquire Lycera upon conclusion of the option period or achievement by Lycera of pre-specified clinical milestones. During the option period, Lycera retained full control of its research and development programs.

The novel technologies are being used for ulcerative colitis drug candidates. Protalix Ltd. is using ProCellEx technology platform for their drug candidates. ProCellEx technology platform overcomes the weaknesses by offering significant production, regulatory and cost benefits.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/ulcerative-colitis-pipeline-analysis/report-sample

Some of the key players developing ulcerative colitis therapeutics include EA Pharma Co., Ltd., Celgene Corporation, InDex Pharmaceuticals AB and others.

Phosphatidylinositol 3-Kinase Inhibitors Pipeline - Clinical Trials & Results, Collaboration and Developments

The PI3K inhibitors pipeline analysis report covers approximately 37 active drug candidates in different stages of development.

Phosphatidylinositol 3-kinases (PI3K) are lipid kinases that are involved in cell regulation, including cell survival, proliferation and differentiation. They act as intermediate molecules in PI3K/AKT/mTOR signaling pathway by sending chemical messengers from cell surface to cytoplasm. These signals activate multiple effector kinase pathways, resulting in survival and growth of normal cells. Phosphatidylinositol 3-kinases is categorized on the basis of classes as class I, II and III, on the basis of structure of the PI3K, based on the specificities of the substrate as well as on the basis of lipid end-product’s nature. Bases on structure, Phosphatidylinositol 3-kinases has four different forms PI3K alpha, PI3K beta, PI3K gamma and PI3K delta.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/phosphoinositide-3-kinase-inhibitor-pipeline-analysis/report-sample

In March 2017, Bayer AG presented clinical results of Phosphoinositide 3-kinase (PI3K)-targeting drug candidate Copanlisib in Phase II CHRONOS-1 trial, evaluating patients with relapsed or refractory indolent non-Hodgkin's lymphoma (iNHL), trial with NCT ID 01660451. The results across all patient groups showed an objective response rate (ORR) of 59.2%, with a 12% complete response (CR) rate and a median duration of response (DOR) of more than 98 weeks, or 687 days (range 0-687).

The research found that different companies engaged in manufacturing of PI3K inhibitors are collaborating. One of the collaborations occurred in November 2016 between Verastem, Inc. and Infinity Pharmaceuticals, Inc.

Pre-Purchase Enquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=phosphoinositide-3-kinase-inhibitor-pipeline-analysis

The major players for PI3K inhibitors pipeline include, but are not limited to, Novartis AG, Genentech, Inc., SignalRX Pharmaceuticals Inc. and others.

Innovating Technologies Offer Development of Novel Therapies

The study analysed that the Synovial sarcoma pipeline comprises of 22 drug candidates in different stages of development. Synovial sarcoma is rare type of cancer and approximately one to three people in one million people are diagnosed with synovial sarcoma every year, globally. The disease occurs frequently in young adults; however, the disease can affect a person at any age. Synovial sarcoma is more common in males, and the male to female ratio of the disease stands at 12 males for every 10 females. Various new therapies and advanced technologies are driving the growth of Synovial sarcoma pipeline.

Browse Report Description at: https://www.psmarketresearch.com/market-analysis/synovial-sarcoma-therapeutics-pipeline-analysis

Many technologies such as REOLYSIN technology, ZVex and GLAAS technology, Laser Micro-beam Microdissection are being developed that can bring the innovative treatment, which can control the progression of Synovial sarcoma.  ZVex and GLAAS are complementary discovery platforms designed to activate and expand the immune system’s natural ability to create tumour-specific cytotoxic T cells (CTLs) in vivo.

The research also found that various companies have collaborated for the development of Synovial sarcoma pipeline. In February 2014, Pfizer Inc. (Pfizer) and Merck & Co., Inc. (Merck) agreed to explore the therapeutic potential of Merck’s investigational anti-PD-1 therapy, MK-3475, in combination with two of the Pfizer’s oncology assets.

Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/synovial-sarcoma-therapeutics-pipeline-analysis/report-sample

Some of the key players developing drugs for Synovial sarcoma include Takara Bio Inc., Oncolytics Biotech Inc., Accuronix Therapeutics, Inc., Cue Biopharma, Inc. and others.